home / stock / mbio / mbio quote
Last: | $0.3211 |
---|---|
Change Percent: | 3.4% |
Open: | $0.31 |
Close: | $0.3211 |
High: | $0.3299 |
Low: | $0.2858 |
Volume: | 1,882,658 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.3211 | $0.31 | $0.3211 | $0.3299 | $0.2858 | 1,882,658 | 07-22-2024 |
$0.3209 | $0.3401 | $0.3209 | $0.35 | $0.3201 | 1,426,698 | 07-19-2024 |
$0.3401 | $0.3701 | $0.3401 | $0.3989 | $0.324 | 2,810,261 | 07-18-2024 |
$0.3676 | $0.4029 | $0.3676 | $0.403 | $0.3633 | 2,043,904 | 07-17-2024 |
$0.4049 | $0.395 | $0.4049 | $0.4129 | $0.395 | 1,243,760 | 07-16-2024 |
$0.396 | $0.4015 | $0.396 | $0.416 | $0.39 | 1,940,842 | 07-15-2024 |
$0.4012 | $0.421 | $0.4012 | $0.4341 | $0.4 | 2,586,190 | 07-12-2024 |
$0.4208 | $0.4404 | $0.4208 | $0.4475 | $0.415 | 1,931,510 | 07-11-2024 |
$0.4423 | $0.4399 | $0.4423 | $0.4598 | $0.4215 | 1,819,870 | 07-10-2024 |
$0.44 | $0.4644 | $0.44 | $0.465 | $0.4 | 3,225,499 | 07-09-2024 |
$0.4603 | $0.49 | $0.4603 | $0.5 | $0.46 | 2,585,046 | 07-08-2024 |
$0.4941 | $0.52 | $0.4941 | $0.52 | $0.48 | 2,487,556 | 07-05-2024 |
$0.4865 | $0.52 | $0.4865 | $0.545 | $0.4829 | 3,881,580 | 07-04-2024 |
$0.4865 | $0.52 | $0.4865 | $0.545 | $0.4829 | 3,881,580 | 07-03-2024 |
$0.559 | $0.4912 | $0.559 | $0.62 | $0.4912 | 20,857,604 | 07-02-2024 |
$0.4844 | $0.4699 | $0.4844 | $0.491 | $0.4625 | 2,671,124 | 07-01-2024 |
$0.473 | $0.4906 | $0.473 | $0.5279 | $0.468 | 5,271,720 | 06-28-2024 |
$0.4656 | $0.43 | $0.4656 | $0.58 | $0.4209 | 18,881,047 | 06-27-2024 |
$0.4438 | $0.46 | $0.4438 | $0.4747 | $0.44 | 5,526,949 | 06-26-2024 |
$0.5001 | $0.5699 | $0.5001 | $0.5713 | $0.4642 | 10,571,561 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB). The update note includes information on the Enveric Bioscience’s ma...
WORCESTER, Mass., June 21, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficul...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...